review
-
Financial
Bioretec Ltd’s business review January-March 2024: Controlled launch in the U.S. progresses
TAMPERE, Finland, May 16, 2024 /PRNewswire/ — This announcement summarizes Bioretec Ltd’s business review for January-March 2024. The complete business review is attached…
Read More » -
Biologics
SpinalCyte, LLC Receives Institutional Review Board Approval for Phase I Clinical Trial
December 13, 2016 HOUSTON–(BUSINESS WIRE)–SpinalCyte, LLC, a Texas-based tissue engineering technology company focused on regrowth of the spinal disc nucleus…
Read More » -
Biologics
New Amniotic “Stem Cell” Review Paper: Misinformed or Misleading?
By Chris Centeno on September 3, 2016 One of the things that’s often hard for patients to understand is that…
Read More » -
Hospitals
SANUWAVE Health Submits de novo Petition for FDA Review and Classification of the dermaPACE System to Treat Diabetic Foot Ulcers
ALPHARETTA, Ga., Aug. 11, 2016 (GLOBE NEWSWIRE) — SANUWAVE Health, Inc. (OTCBB:SNWV) today announced that it has submitted to the…
Read More » -
Hospitals
FDA officials want a national review system for medical devices
July 12, 2016 – By BRAD PERRIELLO A pair of top officials at the FDA are advocating for a national oversight…
Read More » -
Hospitals
Supreme Court declines review in $4m Globus loss to doc inventor
June 21, 2016 By Brad Perriello The U.S. Supreme Court yesterday declined to review Globus Medical‘s (NYSE:GMED) $4.3 million loss to…
Read More » -
Biologics
MiMedx Comments on Flawed Osiris Data Review
MARIETTA, Ga., May 3, 2016 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes…
Read More » -
Osiris Provides an Update on a Clinical Review by Blue Cross Blue Shield Association
COLUMBIA, Md.–(BUSINESS WIRE)– Osiris Therapeutics, Inc. (NASDAQ: OSIR), a leading cellular and regenerative medicine company focused on developing and marketing…
Read More » -
Hospitals
Anika Therapeutics Announces Decision to Proceed with CINGAL® Premarket Review Through FDA’s Center for Drug Evaluation and Research
BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic…
Read More » -
Hospitals
EU drugs agency recommends suspension of Medtronic implant
Europe’s medicines regulator recommended the suspension of Medtronic Plc’s Inductos, an implant used to help bone development, pending the resolution…
Read More » -
Recon
Strategies in the Global Orthopedics Market 2015 – A Review of the Major Geographic Regions, Including U.S, Europe, Japan/Pacific and Others
Research and Markets(http://www.researchandmarkets.com/research/p38drg/2015_strategies) has announced the addition of the “2015 Strategies in the Global Orthopedics Market” report to their offering. This report…
Read More » -
Spine
Medtronic asks Supremes to review loss to NuVasive
By Brad Perriello Medtronic (NYSE:MDT) this month asked the U.S. Supreme Court to review an appeals court’s decision upholding a patent…
Read More » -
Extremities
Salesforce Opens The Door To Competitors
Christine Crandell When Salesforce.com was launched in 2000, it revolutionized the software industry and the cloud movement was born. While…
Read More »